CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Mar. 31, 2022			6,348,314
Beginning balances at Mar. 31, 2022	$ 373,024,428	$ (1,880,346)		$ 280,907,085	$ 92,117,343	$ (1,880,346)
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)			4,300
Proceeds from exercise of stock options	403,547			403,547
Common stock repurchases (in shares)			(73,643)
Common stock repurchases	(14,314,088)				(14,314,088)
Stock-based compensation related to restricted stock, net of cancellations (in shares)			2,750
Stock-based compensation related to restricted stock, net of cancellations	6,191,877			6,191,877
Stock-based compensation (reversal) related to stock options	1,444,759			1,444,759
Net income (loss)	(9,204,051)				(9,204,051)
Ending balance (in shares) at Sep. 30, 2022			6,281,721
Ending balances at Sep. 30, 2022	355,666,126			288,947,268	66,718,858
Beginning balance (in shares) at Jun. 30, 2022			6,280,721
Beginning balances at Jun. 30, 2022	352,483,127			285,126,690	67,356,437
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Stock-based compensation related to restricted stock, net of cancellations (in shares)			1,000
Stock-based compensation related to restricted stock, net of cancellations	3,143,874			3,143,874
Stock-based compensation (reversal) related to stock options	676,704			676,704
Net income (loss)	(637,579)				(637,579)
Ending balance (in shares) at Sep. 30, 2022			6,281,721
Ending balances at Sep. 30, 2022	$ 355,666,126			288,947,268	66,718,858
Beginning balance (in shares) at Mar. 31, 2023	6,231,082		6,231,082
Beginning balances at Mar. 31, 2023	$ 385,226,737			288,071,839	97,154,898
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)			11,743
Proceeds from exercise of stock options	1,069,970			1,069,970
Stock-based compensation related to restricted stock, net of cancellations (in shares)			3,993
Stock-based compensation related to restricted stock, net of cancellations	2,165,851			2,165,851
Stock-based compensation (reversal) related to stock options	(4,060,930)			(4,060,930)
Net income (loss)	$ 25,621,167				25,621,167
Ending balance (in shares) at Sep. 30, 2023	6,246,818		6,246,818
Ending balances at Sep. 30, 2023	$ 410,022,795			287,246,730	122,776,065
Beginning balance (in shares) at Jun. 30, 2023			6,240,497
Beginning balances at Jun. 30, 2023	396,887,477			290,193,831	106,693,646
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Proceeds from exercise of stock options (in shares)			4,203
Proceeds from exercise of stock options	360,676			360,676
Stock-based compensation related to restricted stock, net of cancellations (in shares)			2,118
Stock-based compensation related to restricted stock, net of cancellations	1,066,500			1,066,500
Stock-based compensation (reversal) related to stock options	(4,374,277)			(4,374,277)
Net income (loss)	$ 16,082,419				16,082,419
Ending balance (in shares) at Sep. 30, 2023	6,246,818		6,246,818
Ending balances at Sep. 30, 2023	$ 410,022,795			$ 287,246,730	$ 122,776,065